Hyperuricemia
📧 Sign up to get email alerts when something new happens for Hyperuricemia.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2023-08-09FDA Approved: FEBUXOSTAT — Supplemental Application (DR REDDY'S LABORATORIES LIMITED)
The FDA approved a supplemental application for febuxostat submitted by Dr. Reddy's Laboratories Limited.
-
FDA approval · 2023-08-03FDA Approved: ALLOPURINOL — Original Application (Camber Pharmaceuticals, Inc.)
FDA approved Camber Pharmaceuticals' allopurinol via Original Application (ANDA 217748), granting a generic version of the drug.
-
FDA approval · 2023-07-26FDA Approved: FEBUXOSTAT — Supplemental Application (Alembic Pharmaceuticals Limited)
FDA approved a supplemental application for febuxostat from Alembic Pharmaceuticals Limited. The action indicates regulatory approval for a …
-
FDA approval · 2023-04-17FDA Approved: ULORIC — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
The FDA approved a supplemental application for ULORIC (febuxostat) submitted by Takeda Pharmaceuticals America, Inc. This action updates th…
-
FDA approval · 2023-03-15FDA Approved: ALLOPURINOL — Supplemental Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
The FDA approved a supplemental application for Allopurinol from Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. under ANDA204…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2023-01-12FDA Approved: ALLOPURINOL — Supplemental Application (Unichem Pharmaceuticals (USA), Inc.)
FDA approved a supplemental application for Allopurinol from Unichem Pharmaceuticals (USA), Inc., indicating approval of a supplement to the…
-
FDA approval · 2023-01-09FDA Approved: FEBUXOSTAT — Original Application (Zydus Lifesciences Limited)
FDA approved Zydus Lifesciences Limited's febuxostat Original Application, granting approval for a generic febuxostat product. Febuxostat is…
-
FDA approval · 2022-08-08FDA Approved: ALLOPURINOL — Supplemental Application (Gland Pharma Limited)
FDA approved a supplemental application from Gland Pharma Limited for Allopurinol, enabling the marketing of a generic Allopurinol product u…
-
FDA approval · 2022-08-04FDA Approved: ALLOPURINOL — Supplemental Application (Rising Pharma Holdings, Inc.)
The FDA approved a supplemental application for allopurinol submitted by Rising Pharma Holdings, Inc. This action authorizes a post-approval…
-
FDA approval · 2022-03-28FDA Approved: FEBUXOSTAT — Original Application (Solco Healthcare US LLC)
FDA approved an original abbreviated new drug application for febuxostat submitted by Solco Healthcare US LLC.
-
FDA approval · 2022-03-07FDA Approved: ALLOPURINOL — Original Application (Harman Finochem Limited)
FDA approves the original application for Allopurinol from Harman Finochem Limited.
-
FDA approval · 2022-02-17FDA Approved: ALOPRIM — Supplemental Application (Mylan Institutional LLC)
FDA approved a supplemental application for ALOPRIM (allopurinol) submitted by Mylan Institutional LLC.
-
FDA approval · 2022-01-26FDA Approved: ALLOPURINOL — Original Application (Gland Pharma Limited)
FDA approved the original application for allopurinol from Gland Pharma Limited, enabling a generic version in the United States.
-
FDA approval · 2021-12-07FDA Approved: FEBUXOSTAT — Original Application (Ascend Laboratories, LLC)
The FDA approved Ascend Laboratories, LLC's original application for febuxostat, a generic version of the gout and hyperuricemia medication.
-
FDA approval · 2020-12-16FDA Approved: ALOPRIM — Supplemental Application (Mylan Institutional LLC)
The FDA approved a supplemental application for ALOPRIM (allopurinol) submitted by Mylan Institutional LLC.
-
FDA approval · 2020-10-22FDA Approved: FEBUXOSTAT — Original Application (DR REDDY'S LABORATORIES LIMITED)
FDA approved a generic febuxostat product from Dr. Reddy's Laboratories Limited via an Original Application (ANDA).
-
FDA approval · 2020-08-28FDA Approved: ALOPRIM — Supplemental Application (Mylan Institutional LLC)
FDA approved a supplemental application for ALOPRIM (allopurinol) submitted by Mylan Institutional LLC. The action relates to updates in the…
-
FDA approval · 2020-06-02FDA Approved: FEBUXOSTAT — Original Application (HEC Pharm USA Inc.)
The FDA approved the original application for febuxostat submitted by HEC Pharm USA Inc., authorizing a generic version of febuxostat. Febux…
-
FDA approval · 2019-12-30FDA Approved: FEBUXOSTAT — Original Application (Novadoz Pharmaceuticals LLC)
FDA approved the original Abbreviated New Drug Application for febuxostat (generic) by Novadoz Pharmaceuticals LLC.
-
FDA approval · 2019-12-30FDA Approved: FEBUXOSTAT — Original Application (Tris Pharma Inc)
The FDA approved an original application for febuxostat from Tris Pharma Inc, representing a generic product. The approval covers febuxostat…
-
FDA approval · 2019-12-12FDA Approved: ELITEK — Supplemental Application (Sanofi-Aventis U.S. LLC)
FDA approved a supplemental application for ELITEK (rasburicase) submitted by Sanofi-Aventis U.S. LLC.
-
FDA approval · 2019-10-15FDA Approved: FEBUXOSTAT — Original Application (Hikma Pharmaceuticals USA Inc)
FDA approved Hikma Pharmaceuticals USA Inc for a generic febuxostat via an original ANDA (ANDA205414). This approval expands access to urate…
-
FDA approval · 2019-07-01FDA Approved: FEBUXOSTAT — Original Application (Sun Pharmaceutical Industries, Inc.)
FDA approves Sun Pharmaceutical Industries' original application for febuxostat (generic febuxostat). This ANDA approval provides a generic …
-
FDA approval · 2019-07-01FDA Approved: FEBUXOSTAT — Original Application (Alembic Pharmaceuticals Limited)
FDA approved Alembic Pharmaceuticals Limited's original ANDA for febuxostat, a generic version of the gout and hyperuricemia therapy.
-
FDA approval · 2019-04-23FDA Approved: ALLOPURINOL — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for Allopurinol from Mylan Pharmaceuticals Inc., representing a supplemental approval for the produc…